Zimmer Biomet vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Zimmer Biomet (ZBH) reported ~$7.7B revenue in FY2024. Leading maker of orthopedic implants for knee and hip replacement surgeries, with robotics and digital surgery platforms. HQ: Warsaw, IN.
About
Zimmer Biomet Holdings, Inc. is one of the world's largest musculoskeletal healthcare companies, designing, manufacturing, and distributing orthopedic implants, spinal devices, dental implants, and surgical instrumentation. The company's core products are total knee and total hip replacement systems — the implants that allow surgeons to replace arthritic or damaged joints, enabling millions of patients to regain mobility and reduce chronic pain. Formed through Zimmer Holdings' $13.4 billion acquisition of Biomet in 2015, the company serves over 25 million patients annually.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.